Fig. 1
Overall survival data in 536 Mayo Clinic patients with chronic myelomonocytic leukemia, stratified by the number of TET2 mutations—calculated from the time of mutation detection and censored for allogeneic stem cell transplantation.
Fig. 1 | Blood Cancer Journal
